The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nordurine 0.2 mg Tablets



Ferring Ireland LtdPA1009/017/002

Main Information

Trade NameNordurine 0.2 mg Tablets
Active SubstancesDESMOPRESSIN ACETATE
Dosage FormTablet
Licence HolderFerring Ireland Ltd
Licence NumberPA1009/017/002

Group Information

ATC CodeH01BA Vasopressin and analogues
H01BA02 desmopressin

Status

License statusAuthorised
Licence Issued25/07/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to market only product authorised in Ireland under the product authorisation number PA 1009/007/001.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back